Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Takemura K, Yuasa T, Lemelin A, Ferrier E, Wells JC, Saad E, Saliby RM, Basappa NS, Wood LA, Jude E, Pal SK, Donskov F, Beuselinck B, Szabados B, Powles T, McKay RR, Gebrael G, Agarwal N, Choueiri TK, Heng DYC. Takemura K, et al. Among authors: saad e. ESMO Open. 2024 Jul;9(7):103606. doi: 10.1016/j.esmoop.2024.103606. Epub 2024 Jun 19. ESMO Open. 2024. PMID: 38901174 Free PMC article.
Oligometastatic Bladder Cancer: Defining a Novel Entity.
Labaki C, Saad E, Choueiri TK, Bellmunt J. Labaki C, et al. Among authors: saad e. Eur Urol. 2023 Oct;84(4):390-392. doi: 10.1016/j.eururo.2023.06.003. Epub 2023 Jul 5. Eur Urol. 2023. PMID: 37414704 No abstract available.
Update on Biomarkers in Renal Cell Carcinoma.
Saliby RM, Saad E, Kashima S, Schoenfeld DA, Braun DA. Saliby RM, et al. Among authors: saad e. Am Soc Clin Oncol Educ Book. 2024 Jan;44(2):e430734. doi: 10.1200/EDBK_430734. Am Soc Clin Oncol Educ Book. 2024. PMID: 38207251 Free article.
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes.
Saliby RM, Labaki C, Jammihal TR, Xie W, Sun M, Shah V, Saad E, Kane MH, Kashima S, Sadak K, El Zarif T, Poduval D, Motzer RJ, Powles T, Rini BI, Albiges L, Pal SK, McGregor BA, McKay RR, Signoretti S, Van Allen EM, Shukla SA, Choueiri TK, Braun DA. Saliby RM, et al. Among authors: saad e. Cancer Cell. 2024 May 13;42(5):732-735. doi: 10.1016/j.ccell.2024.03.002. Epub 2024 Apr 4. Cancer Cell. 2024. PMID: 38579722
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Saad E, Gebrael G, Semaan K, Eid M, Saliby RM, Labaki C, Sayegh N, Wells JC, Takemura K, Ernst MS, Lemelin A, Basappa NS, Wood LA, Powles T, Ernst DS, Lalani AA, Agarwal N, Xie W, Heng DYC, Choueiri TK. Saad E, et al. Oncologist. 2024 Aug 5;29(8):699-706. doi: 10.1093/oncolo/oyae072. Oncologist. 2024. PMID: 38630540 Free PMC article.
First and Second-line Treatments in Metastatic Renal Cell Carcinoma.
Barragan-Carrillo R, Saad E, Saliby RM, Sun M, Albiges L, Bex A, Heng D, Mejean A, Motzer RJ, Plimack ER, Powles T, Rini BI, Zhang T, Choueiri TK. Barragan-Carrillo R, et al. Among authors: saad e. Eur Urol. 2024 Nov 5:S0302-2838(24)02681-2. doi: 10.1016/j.eururo.2024.10.019. Online ahead of print. Eur Urol. 2024. PMID: 39505582 Review.
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma.
Panian J, Zhong C, Choi SH, Ly K, Quinn R, Ferrier E, Saad E, Saliby RM, Malvar C, Pal S, Ebrahimi H, Tran B, Jude E, Lalani AK, Suarez C, Velasco G, Kanesvaran R, Zarba M, Liow E, El Hajj Chehade R, Choueiri TK, Heng DYC, McKay RR. Panian J, et al. Among authors: saad e. Eur Urol Focus. 2024 Dec 7:S2405-4569(24)00257-8. doi: 10.1016/j.euf.2024.11.011. Online ahead of print. Eur Urol Focus. 2024. PMID: 39648092
Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice.
Dizman N, Bakouny Z, Haykal T, Riano I, Desai A, Butt A, Basu A, Zhao D, Saad E, Saliby RM, Gosain R, Gosain R, Ardeshir F, Deng L, Matt-Amaral L, Arnaoutakis K, Bekaii-Saab T, Manochakian R, Marshall A, Forde P, Murphy M, Subbiah V, Chavez-MacGregor M, Owonikoko TK, Lopes G, Aggarwal C, Lee AI, Choueiri TK. Dizman N, et al. Among authors: saad e. JCO Oncol Pract. 2024 Oct 7:OP2400565. doi: 10.1200/OP-24-00565. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39374449
558 results